Bound states of solitons in a fiber laser mode locked with carbon nanotube saturable absorber von Wu, X., Tang, D.Y., Luan, X.N., Zhang, Q.

Volltext

Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study von Yan, X.Q., Ye, M.J., Zou, Q., Chen, P., He, Z.S., Wu, B., He, D.L., He, C.H., Xue, X.Y., Ji, Z.G., Chen, H., Zhang, S., Liu, Y.P., Zhang, X.D., Fu, C., Xu, D.F., Qiu, M.X., Lv, J.J., Huang, J., Ren, X.B., Cheng, Y., Qin, W.J., Zhang, X., Zhou, F.J., Ma, L.L., Guo, J.M., Ding, D.G., Wei, S.Z., He, Y., Guo, H.Q., Shi, B.K., Liu, L., Liu, F., Hu, Z.Q., Jin, X.M., Yang, L., Zhu, S.X., Liu, J.H., Huang, Y.H., Xu, T., Liu, B., Sun, T., Wang, Z.J., Jiang, H.W., Yu, D.X., Zhou, A.P., Jiang, J., Luan, G.D., Jin, C.L., Xu, J., Hu, J.X., Huang, Y.R., Guo, J., Zhai, W., Sheng, X.N.

Volltext